VRTX logo

VRTX Free cash flow

annual FCF:

-$978.00M-$4.26B(-129.83%)
December 31, 2024

Summary

  • As of today (August 18, 2025), VRTX annual free cash flow is -$978.00 million, with the most recent change of -$4.26 billion (-129.83%) on December 31, 2024.
  • During the last 3 years, VRTX annual FCF has fallen by -$3.39 billion (-140.61%).
  • VRTX annual FCF is now -124.92% below its all-time high of $3.93 billion, reached on December 31, 2022.

Performance

VRTX Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRTXcash flow metrics

quarterly FCF:

$927.40M+$149.20M(+19.17%)
June 30, 2025

Summary

  • As of today (August 18, 2025), VRTX quarterly free cash flow is $927.40 million, with the most recent change of +$149.20 million (+19.17%) on June 30, 2025.
  • Over the past year, VRTX quarterly FCF has increased by +$4.76 billion (+124.21%).
  • VRTX quarterly FCF is now -28.78% below its all-time high of $1.30 billion, reached on September 30, 2024.

Performance

VRTX quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRTXcash flow metrics

TTM FCF:

$3.50B+$4.76B(+378.20%)
June 30, 2025

Summary

  • As of today (August 18, 2025), VRTX TTM free cash flow is $3.50 billion, with the most recent change of +$4.76 billion (+378.20%) on June 30, 2025.
  • Over the past year, VRTX TTM FCF has increased by +$4.93 billion (+345.46%).
  • VRTX TTM FCF is now -16.78% below its all-time high of $4.21 billion, reached on September 30, 2023.

Performance

VRTX TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRTXcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

VRTX Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-129.8%+124.2%+345.5%
3 y3 years-140.6%-14.6%-7.6%
5 y5 years-165.5%-9.1%+36.9%

VRTX Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-124.9%at low-28.8%+124.2%-16.8%+345.5%
5 y5-year-124.9%at low-28.8%+124.2%-16.8%+345.5%
alltimeall time-124.9%at low-28.8%+124.2%-16.8%+345.5%

VRTX Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
$927.40M(+19.2%)
$3.50B(-378.2%)
Mar 2025
-
$778.20M(+58.2%)
-$1.26B(+28.6%)
Dec 2024
-$978.00M(-129.8%)
$492.00M(-62.2%)
-$978.00M(-27.6%)
Sep 2024
-
$1.30B(-134.0%)
-$1.35B(-5.2%)
Jun 2024
-
-$3.83B(-462.0%)
-$1.43B(-141.0%)
Mar 2024
-
$1.06B(+793.0%)
$3.48B(+6.1%)
Dec 2023
$3.28B(-16.5%)
$118.50M(-90.3%)
$3.28B(-22.0%)
Sep 2023
-
$1.23B(+14.2%)
$4.21B(+8.4%)
Jun 2023
-
$1.07B(+25.3%)
$3.88B(-0.3%)
Mar 2023
-
$857.80M(-17.9%)
$3.89B(-0.9%)
Dec 2022
$3.93B(+63.0%)
$1.04B(+15.9%)
$3.93B(+2.9%)
Sep 2022
-
$901.30M(-17.0%)
$3.81B(+0.7%)
Jun 2022
-
$1.09B(+21.7%)
$3.79B(+54.5%)
Mar 2022
-
$892.60M(-4.4%)
$2.45B(+1.8%)
Dec 2021
$2.41B(-19.5%)
$933.28M(+6.7%)
$2.41B(+25.5%)
Sep 2021
-
$874.70M(-450.4%)
$1.92B(+8.0%)
Jun 2021
-
-$249.60M(-129.4%)
$1.78B(-41.7%)
Mar 2021
-
$850.13M(+91.5%)
$3.05B(+1.8%)
Dec 2020
$2.99B(+100.4%)
$443.84M(-39.4%)
$2.99B(+0.5%)
Sep 2020
-
$732.95M(-28.2%)
$2.98B(+16.5%)
Jun 2020
-
$1.02B(+28.2%)
$2.56B(+28.9%)
Mar 2020
-
$796.25M(+85.5%)
$1.98B(+32.8%)
Dec 2019
$1.49B(+27.2%)
$429.25M(+38.2%)
$1.49B(+9.6%)
Sep 2019
-
$310.50M(-30.6%)
$1.36B(-3.5%)
Jun 2019
-
$447.39M(+45.9%)
$1.41B(+12.3%)
Mar 2019
-
$306.74M(+2.6%)
$1.26B(+7.1%)
Dec 2018
$1.17B(+100.6%)
$298.86M(-17.1%)
$1.17B(+10.7%)
Sep 2018
-
$360.44M(+23.4%)
$1.06B(+55.5%)
Jun 2018
-
$292.09M(+30.8%)
$682.12M(+23.0%)
Mar 2018
-
$223.38M(+20.8%)
$554.37M(-5.3%)
Dec 2017
$585.52M(+226.1%)
$184.91M(-1113.0%)
$585.52M(+10.3%)
Sep 2017
-
-$18.25M(-111.1%)
$530.63M(-11.7%)
Jun 2017
-
$164.34M(-35.4%)
$600.73M(+30.3%)
Mar 2017
-
$254.53M(+95.8%)
$461.18M(+156.9%)
Dec 2016
$179.53M(-143.7%)
$130.02M(+150.8%)
$179.53M(+717.7%)
Sep 2016
-
$51.84M(+109.2%)
$21.95M(-125.3%)
Jun 2016
-
$24.78M(-191.4%)
-$86.69M(-60.6%)
Mar 2016
-
-$27.11M(-1.6%)
-$220.11M(-46.4%)
Dec 2015
-$410.73M(-27.3%)
-$27.56M(-51.5%)
-$410.73M(-21.0%)
Sep 2015
-
-$56.80M(-47.7%)
-$519.97M(-7.2%)
Jun 2015
-
-$108.63M(-50.1%)
-$560.11M(-5.2%)
Mar 2015
-
-$217.74M(+59.2%)
-$591.10M(+4.7%)
Dec 2014
-$564.64M(+448.4%)
-$136.79M(+41.1%)
-$564.64M(+36.6%)
Sep 2014
-
-$96.94M(-30.6%)
-$413.47M(+18.6%)
Jun 2014
-
-$139.62M(-27.0%)
-$348.76M(+64.6%)
Mar 2014
-
-$191.29M(-1429.9%)
-$211.87M(+105.8%)
Dec 2013
-$102.96M(-152.6%)
$14.38M(-144.6%)
-$102.96M(-1.6%)
Sep 2013
-
-$32.23M(+1081.6%)
-$104.66M(-1000.4%)
Jun 2013
-
-$2.73M(-96.7%)
$11.62M(-90.1%)
Mar 2013
-
-$82.39M(-749.5%)
$116.94M(-40.3%)
Dec 2012
$195.88M(+79.8%)
$12.68M(-84.9%)
$195.88M(-71.1%)
Sep 2012
-
$84.05M(-18.1%)
$677.89M(+8.2%)
Jun 2012
-
$102.59M(-3069.4%)
$626.55M(+110.6%)
Mar 2012
-
-$3.46M(-100.7%)
$297.52M(+173.1%)
Dec 2011
$108.96M(-116.2%)
$494.70M(+1412.1%)
$108.96M(-119.2%)
Sep 2011
-
$32.72M(-114.4%)
-$566.36M(-26.8%)
Jun 2011
-
-$226.43M(+17.9%)
-$773.85M(+16.1%)
Mar 2011
-
-$192.02M(+6.3%)
-$666.52M(-1.2%)
Dec 2010
-$674.45M(+49.5%)
-$180.62M(+3.3%)
-$674.45M(+11.7%)
Sep 2010
-
-$174.78M(+46.7%)
-$603.73M(+32.6%)
Jun 2010
-
-$119.10M(-40.4%)
-$455.34M(-0.8%)
Mar 2010
-
-$199.95M(+81.9%)
-$458.90M(+1.7%)
Dec 2009
-$451.08M(+73.9%)
-$109.91M(+316.5%)
-$451.08M(+1.3%)
Sep 2009
-
-$26.39M(-78.5%)
-$445.35M(-20.0%)
Jun 2009
-
-$122.65M(-36.2%)
-$556.36M(+63.6%)
Mar 2009
-
-$192.14M(+84.4%)
-$340.10M(+31.1%)
Dec 2008
-$259.36M
-$104.17M(-24.2%)
-$259.36M(+21.7%)
DateAnnualQuarterlyTTM
Sep 2008
-
-$137.40M(-246.8%)
-$213.08M(+44.7%)
Jun 2008
-
$93.61M(-184.0%)
-$147.25M(-54.3%)
Mar 2008
-
-$111.40M(+92.4%)
-$322.35M(+13.1%)
Dec 2007
-$284.89M(+419.0%)
-$57.89M(-19.1%)
-$284.89M(+19.5%)
Sep 2007
-
-$71.57M(-12.2%)
-$238.31M(+230.1%)
Jun 2007
-
-$81.49M(+10.2%)
-$72.18M(+19.3%)
Mar 2007
-
-$73.94M(+554.1%)
-$60.51M(+10.2%)
Dec 2006
-$54.89M(-71.0%)
-$11.30M(-112.0%)
-$54.89M(-1.5%)
Sep 2006
-
$94.55M(-235.4%)
-$55.70M(-73.6%)
Jun 2006
-
-$69.82M(+2.2%)
-$211.05M(+5.9%)
Mar 2006
-
-$68.32M(+463.9%)
-$199.28M(+5.4%)
Dec 2005
-$189.03M(+22.1%)
-$12.12M(-80.1%)
-$189.03M(-7.5%)
Sep 2005
-
-$60.79M(+4.7%)
-$204.36M(+8.1%)
Jun 2005
-
-$58.05M(-0.0%)
-$189.07M(+19.7%)
Mar 2005
-
-$58.07M(+111.6%)
-$157.98M(+2.1%)
Dec 2004
-$154.79M(-16.3%)
-$27.45M(-39.7%)
-$154.66M(-3.2%)
Sep 2004
-
-$45.51M(+68.8%)
-$159.76M(-1.0%)
Jun 2004
-
-$26.95M(-50.8%)
-$161.41M(-11.7%)
Mar 2004
-
-$54.75M(+68.2%)
-$182.71M(-1.2%)
Dec 2003
-$184.97M(+53.2%)
-$32.55M(-31.0%)
-$184.97M(+4.8%)
Sep 2003
-
-$47.15M(-2.3%)
-$176.46M(+10.3%)
Jun 2003
-
-$48.26M(-15.3%)
-$160.00M(+16.2%)
Mar 2003
-
-$57.01M(+137.2%)
-$137.68M(+14.0%)
Dec 2002
-$120.76M(+94.9%)
-$24.04M(-21.7%)
-$120.76M(+82.4%)
Sep 2002
-
-$30.68M(+18.3%)
-$66.19M(-31.4%)
Jun 2002
-
-$25.94M(-35.3%)
-$96.53M(+15.6%)
Mar 2002
-
-$40.09M(-231.3%)
-$83.50M(+34.7%)
Dec 2001
-$61.97M(+115.3%)
$30.53M(-150.0%)
-$61.97M(-44.7%)
Sep 2001
-
-$61.03M(+372.9%)
-$112.14M(+77.9%)
Jun 2001
-
-$12.90M(-30.5%)
-$63.03M(+117.9%)
Mar 2001
-
-$18.57M(-5.4%)
-$28.92M(+1.3%)
Dec 2000
-$28.79M(-40.0%)
-$19.63M(+64.7%)
-$28.56M(+1061.3%)
Sep 2000
-
-$11.92M(-156.2%)
-$2.46M(-74.6%)
Jun 2000
-
$21.20M(-216.5%)
-$9.70M(-80.2%)
Mar 2000
-
-$18.20M(-381.6%)
-$48.89M(+1.8%)
Dec 1999
-$48.02M(+23.3%)
$6.46M(-133.7%)
-$48.02M(-28.8%)
Sep 1999
-
-$19.16M(+6.5%)
-$67.44M(+39.0%)
Jun 1999
-
-$17.99M(+3.8%)
-$48.51M(+15.9%)
Mar 1999
-
-$17.33M(+33.7%)
-$41.86M(+7.5%)
Dec 1998
-$38.96M(+150.0%)
-$12.96M(+5611.5%)
-$38.96M(+24.1%)
Sep 1998
-
-$227.00K(-98.0%)
-$31.39M(-10.5%)
Jun 1998
-
-$11.34M(-21.4%)
-$35.06M(+41.3%)
Mar 1998
-
-$14.42M(+167.1%)
-$24.82M(+61.2%)
Dec 1997
-$15.58M(-64.8%)
-$5.40M(+38.5%)
-$15.40M(+1.3%)
Sep 1997
-
-$3.90M(+254.5%)
-$15.20M(-19.1%)
Jun 1997
-
-$1.10M(-78.0%)
-$18.80M(-53.5%)
Mar 1997
-
-$5.00M(-3.8%)
-$40.40M(-8.8%)
Dec 1996
-$44.24M(+131.7%)
-$5.20M(-30.7%)
-$44.30M(+4.2%)
Sep 1996
-
-$7.50M(-67.0%)
-$42.50M(+6.0%)
Jun 1996
-
-$22.70M(+155.1%)
-$40.10M(+61.7%)
Mar 1996
-
-$8.90M(+161.8%)
-$24.80M(+15.9%)
Dec 1995
-$19.09M(+10.5%)
-$3.40M(-33.3%)
-$21.40M(-10.1%)
Sep 1995
-
-$5.10M(-31.1%)
-$23.80M(+10.2%)
Jun 1995
-
-$7.40M(+34.5%)
-$21.60M(+24.9%)
Mar 1995
-
-$5.50M(-5.2%)
-$17.30M(+4.2%)
Dec 1994
-$17.28M(-354.7%)
-$5.80M(+100.0%)
-$16.60M(+1975.0%)
Sep 1994
-
-$2.90M(-6.5%)
-$800.00K(-144.4%)
Jun 1994
-
-$3.10M(-35.4%)
$1.80M(-64.7%)
Mar 1994
-
-$4.80M(-148.0%)
$5.10M(-25.0%)
Dec 1993
$6.79M(-203.3%)
$10.00M(-3433.3%)
$6.80M(-215.3%)
Sep 1993
-
-$300.00K(-250.0%)
-$5.90M(-10.6%)
Jun 1993
-
$200.00K(-106.5%)
-$6.60M(-13.2%)
Mar 1993
-
-$3.10M(+14.8%)
-$7.60M(+11.8%)
Dec 1992
-$6.57M(+70.6%)
-$2.70M(+170.0%)
-$6.80M(+65.9%)
Sep 1992
-
-$1.00M(+25.0%)
-$4.10M(+32.3%)
Jun 1992
-
-$800.00K(-65.2%)
-$3.10M(+34.8%)
Mar 1992
-
-$2.30M
-$2.30M
Dec 1991
-$3.85M
-
-

FAQ

  • What is Vertex Pharmaceuticals Incorporated annual free cash flow?
  • What is the all time high annual FCF for Vertex Pharmaceuticals Incorporated?
  • What is Vertex Pharmaceuticals Incorporated annual FCF year-on-year change?
  • What is Vertex Pharmaceuticals Incorporated quarterly free cash flow?
  • What is the all time high quarterly FCF for Vertex Pharmaceuticals Incorporated?
  • What is Vertex Pharmaceuticals Incorporated quarterly FCF year-on-year change?
  • What is Vertex Pharmaceuticals Incorporated TTM free cash flow?
  • What is the all time high TTM FCF for Vertex Pharmaceuticals Incorporated?
  • What is Vertex Pharmaceuticals Incorporated TTM FCF year-on-year change?

What is Vertex Pharmaceuticals Incorporated annual free cash flow?

The current annual FCF of VRTX is -$978.00M

What is the all time high annual FCF for Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated all-time high annual free cash flow is $3.93B

What is Vertex Pharmaceuticals Incorporated annual FCF year-on-year change?

Over the past year, VRTX annual free cash flow has changed by -$4.26B (-129.83%)

What is Vertex Pharmaceuticals Incorporated quarterly free cash flow?

The current quarterly FCF of VRTX is $927.40M

What is the all time high quarterly FCF for Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated all-time high quarterly free cash flow is $1.30B

What is Vertex Pharmaceuticals Incorporated quarterly FCF year-on-year change?

Over the past year, VRTX quarterly free cash flow has changed by +$4.76B (+124.21%)

What is Vertex Pharmaceuticals Incorporated TTM free cash flow?

The current TTM FCF of VRTX is $3.50B

What is the all time high TTM FCF for Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated all-time high TTM free cash flow is $4.21B

What is Vertex Pharmaceuticals Incorporated TTM FCF year-on-year change?

Over the past year, VRTX TTM free cash flow has changed by +$4.93B (+345.46%)
On this page